ISMPP Highlights
GPP4: Development Is Underway
ISMPP is honored to have the opportunity to sponsor the next iteration of the Good Publication Practice (GPP) guidelines, an industry-leading document to guide the ethical development of medical publications. Development of the GPP4 guidelines is now well underway, with a Steering Committee established and working steadily on revisions to the guidance…
Open Pharma Releases Position Statement on Open Access
Open Pharma recently released its Position Statement on Open Access, which advocates that access to pharmaceutical company-funded research should not be restricted by journal paywalls. The Position Statement points out that approximately half of all biomedical research is funded by pharmaceutical companies. In the Position Statement, Open Pharma sets out its…
It’s Not Who You Are, It’s What You Do: Determining Authorship for Industry-sponsored Publications
Challenges with authorship of industry-sponsored publications persist despite established guidelines and recommendations. While adherence to the ICMJE authorship recommendations is an accepted standard across the industry, there is considerable ambiguity in…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Scientific Communication Platforms: Highlighting Current Best Practices
Scientific communication platforms (SCPs) were first introduced into pharmaceutical practices more than a decade ago. Since their introduction, SCPs have evolved to keep pace with the ever-changing needs of the healthcare landscape…
Death by PowerPoint is a Preventable Condition
Despite presentations having long been at the heart of communication within our industry, they are still a format we struggle to optimize. Following our practical and well-received parallel session, Working with PowerPoint as your Co-presenter, at the 15th Annual Meeting of ISMPP…
Publication Planning at Smaller Companies: Top 5 Learnings for Success
Generating and deploying a robust publication plan at a smaller or earlier-stage company, where resources may be scarce, budgets low, and awareness of best practices limited, presents a unique set of challenges…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Preprint Review Results in Added Author?
An external author posts the first draft of a preclinical manuscript on his/her department preprint server to invite review and comments from colleagues who performed some of the work yet did not meet all ICMJE criteria for full authorship. This author is now petitioning the author group to add one more colleague who provided insightful comments to the author byline…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals